Back

REVERSE-AF Score: development of a clinical tool to predict atrial fibrillation recurrence after electrical cardioversion

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Mariana Santos Silva

Centro Hospitalar do Baixo Vouga, Aveiro (Portugal)

5 More presentations in this session

Presentation thumbnail
Peak atrial longitudinal strain in predicting recurrence of atrial fibrillation after cardioversion
Doctor A. Garner (Slagelse, DK)
Abstract
Presentation thumbnail
Predictors of long-term atrial fibrillation recurrence following catheter ablation: a UK multicenter study
Doctor N. Chandan (Coventry, GB)
Abstract
Presentation thumbnail
Baseline multidomain atrial vulnerability stratifies recurrence after AF ablation in elderly patients
Professor D. Malidze (Tbilisi, GE)
Abstract
Presentation thumbnail
Plasma level of extracellular matrix biomarkers is associated with the recurrence of atrial fibrillation
Mr S. Andrup (Oslo, NO)
Abstract
Presentation thumbnail
SCN5A H558R polymorphism reduces the risk of flecainide-related toxicity and inefficacy
Mr M. Trincado Ave (Santiago de Compostela, ES)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation recurrence: clinical, genetic, and biomarker predictors

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
A simplified ECG-based tool for predicting atrial fibrillation recurrence after electrical cardioversion: the RECAF-score
18 May 2025
thumbnail
Congress Presentation
Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)
30 August 2020
thumbnail
Congress Presentation
Presence and predictors of atrial low voltage zones in patients with non cardiovertable atrial fibrillation
7 April 2024
thumbnail
Congress Presentation
Obstructive sleep apnea assessment using a wearable medical device in patients post-catheter ablation for atrial fibrillation: Validation and predictive value.
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources